FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073821132> ?p ?o ?g. }

• W2073821132 endingPage "1929" @default.
• W2073821132 startingPage "1921" @default.
• W2073821132 abstract "BackgroundNumerous studies have supported the effectiveness of recombinant activated factor VII (rFVIIa) for the control of bleeding after cardiac procedures; however safety concerns persist. Here we report the novel use of intraoperative low-dose rFVIIa in thoracic aortic operations, a strategy intended to improve safety by minimizing rFVIIa exposure.MethodsBetween July 2005 and December 2010, 425 consecutive patients at a single referral center underwent thoracic aortic operations with cardiopulmonary bypass (CPB); 77 of these patients received intraoperative low-dose rFVIIa (≤60 μg/kg) for severe coagulopathy after CPB. Propensity matching produced a cohort of 88 patients (44 received intraoperative low-dose rFVIIa and 44 controls) for comparison.ResultsMatched patients receiving intraoperative low-dose rFVIIa got an initial median dose of 32 μg/kg (interquartile range [IQR], 16–43 μg/kg) rFVIIa given 51 minutes (42–67 minutes) after separation from CPB. Patients receiving intraoperative low-dose rFVIIa demonstrated improved postoperative coagulation measurements (partial thromboplastin time 28.6 versus 31.5 seconds; p = 0.05; international normalized ratio, 0.8 versus 1.2; p < 0.0001) and received 50% fewer postoperative blood product transfusions (2.5 versus 5.0 units; p = 0.05) compared with control patients. No patient receiving intraoperative low-dose rFVIIa required postoperative rFVIIa administration or reexploration for bleeding. Rates of stroke, thromboembolism, myocardial infarction, and other adverse events were equivalent between groups.ConclusionsIntraoperative low-dose rFVIIa led to improved postoperative hemostasis with no apparent increase in adverse events. Intraoperative rFVIIa administration in appropriately selected patients may correct coagulopathy early in the course of refractory blood loss and lead to improved safety through the use of smaller rFVIIa doses. Appropriately powered randomized studies are necessary to confirm the safety and efficacy of this approach. Numerous studies have supported the effectiveness of recombinant activated factor VII (rFVIIa) for the control of bleeding after cardiac procedures; however safety concerns persist. Here we report the novel use of intraoperative low-dose rFVIIa in thoracic aortic operations, a strategy intended to improve safety by minimizing rFVIIa exposure. Between July 2005 and December 2010, 425 consecutive patients at a single referral center underwent thoracic aortic operations with cardiopulmonary bypass (CPB); 77 of these patients received intraoperative low-dose rFVIIa (≤60 μg/kg) for severe coagulopathy after CPB. Propensity matching produced a cohort of 88 patients (44 received intraoperative low-dose rFVIIa and 44 controls) for comparison. Matched patients receiving intraoperative low-dose rFVIIa got an initial median dose of 32 μg/kg (interquartile range [IQR], 16–43 μg/kg) rFVIIa given 51 minutes (42–67 minutes) after separation from CPB. Patients receiving intraoperative low-dose rFVIIa demonstrated improved postoperative coagulation measurements (partial thromboplastin time 28.6 versus 31.5 seconds; p = 0.05; international normalized ratio, 0.8 versus 1.2; p < 0.0001) and received 50% fewer postoperative blood product transfusions (2.5 versus 5.0 units; p = 0.05) compared with control patients. No patient receiving intraoperative low-dose rFVIIa required postoperative rFVIIa administration or reexploration for bleeding. Rates of stroke, thromboembolism, myocardial infarction, and other adverse events were equivalent between groups. Intraoperative low-dose rFVIIa led to improved postoperative hemostasis with no apparent increase in adverse events. Intraoperative rFVIIa administration in appropriately selected patients may correct coagulopathy early in the course of refractory blood loss and lead to improved safety through the use of smaller rFVIIa doses. Appropriately powered randomized studies are necessary to confirm the safety and efficacy of this approach." @default.
• W2073821132 created "2016-06-24" @default.
• W2073821132 creator A5006029800 @default.
• W2073821132 creator A5018571955 @default.
• W2073821132 creator A5020637999 @default.
• W2073821132 creator A5022126559 @default.
• W2073821132 creator A5025654306 @default.
• W2073821132 creator A5052724348 @default.
• W2073821132 creator A5077565346 @default.
• W2073821132 creator A5079554307 @default.
• W2073821132 creator A5086401839 @default.
• W2073821132 date "2012-06-01" @default.
• W2073821132 modified "2023-10-06" @default.
• W2073821132 title "Intraoperative Use of Low-Dose Recombinant Activated Factor VII During Thoracic Aortic Operations" @default.
• W2073821132 cites W1965564230 @default.
• W2073821132 cites W1972778390 @default.
• W2073821132 cites W1977148300 @default.
• W2073821132 cites W2000354927 @default.
• W2073821132 cites W2009658870 @default.
• W2073821132 cites W2012122808 @default.
• W2073821132 cites W2019635214 @default.
• W2073821132 cites W2026851381 @default.
• W2073821132 cites W2042759105 @default.
• W2073821132 cites W2051548515 @default.
• W2073821132 cites W2073752601 @default.
• W2073821132 cites W2121903458 @default.
• W2073821132 cites W2123339289 @default.
• W2073821132 cites W2123785333 @default.
• W2073821132 cites W2144423309 @default.
• W2073821132 cites W2144905246 @default.
• W2073821132 cites W2146197275 @default.
• W2073821132 cites W2268967330 @default.
• W2073821132 cites W2416910173 @default.
• W2073821132 doi "https://doi.org/10.1016/j.athoracsur.2012.02.037" @default.
• W2073821132 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3718882" @default.
• W2073821132 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22551846" @default.
• W2073821132 hasPublicationYear "2012" @default.
• W2073821132 type Work @default.
• W2073821132 sameAs 2073821132 @default.
• W2073821132 citedByCount "51" @default.
• W2073821132 countsByYear W20738211322012 @default.
• W2073821132 countsByYear W20738211322014 @default.
• W2073821132 countsByYear W20738211322015 @default.
• W2073821132 countsByYear W20738211322016 @default.
• W2073821132 countsByYear W20738211322017 @default.
• W2073821132 countsByYear W20738211322018 @default.
• W2073821132 countsByYear W20738211322019 @default.
• W2073821132 countsByYear W20738211322020 @default.
• W2073821132 countsByYear W20738211322021 @default.
• W2073821132 countsByYear W20738211322022 @default.
• W2073821132 countsByYear W20738211322023 @default.
• W2073821132 crossrefType "journal-article" @default.
• W2073821132 hasAuthorship W2073821132A5006029800 @default.
• W2073821132 hasAuthorship W2073821132A5018571955 @default.
• W2073821132 hasAuthorship W2073821132A5020637999 @default.
• W2073821132 hasAuthorship W2073821132A5022126559 @default.
• W2073821132 hasAuthorship W2073821132A5025654306 @default.
• W2073821132 hasAuthorship W2073821132A5052724348 @default.
• W2073821132 hasAuthorship W2073821132A5077565346 @default.
• W2073821132 hasAuthorship W2073821132A5079554307 @default.
• W2073821132 hasAuthorship W2073821132A5086401839 @default.
• W2073821132 hasBestOaLocation W20738211322 @default.
• W2073821132 hasConcept C119060515 @default.
• W2073821132 hasConcept C126322002 @default.
• W2073821132 hasConcept C141071460 @default.
• W2073821132 hasConcept C197934379 @default.
• W2073821132 hasConcept C2778261982 @default.
• W2073821132 hasConcept C2778382381 @default.
• W2073821132 hasConcept C2778881276 @default.
• W2073821132 hasConcept C2779936836 @default.
• W2073821132 hasConcept C42219234 @default.
• W2073821132 hasConcept C71924100 @default.
• W2073821132 hasConceptScore W2073821132C119060515 @default.
• W2073821132 hasConceptScore W2073821132C126322002 @default.
• W2073821132 hasConceptScore W2073821132C141071460 @default.
• W2073821132 hasConceptScore W2073821132C197934379 @default.
• W2073821132 hasConceptScore W2073821132C2778261982 @default.
• W2073821132 hasConceptScore W2073821132C2778382381 @default.
• W2073821132 hasConceptScore W2073821132C2778881276 @default.
• W2073821132 hasConceptScore W2073821132C2779936836 @default.
• W2073821132 hasConceptScore W2073821132C42219234 @default.
• W2073821132 hasConceptScore W2073821132C71924100 @default.
• W2073821132 hasIssue "6" @default.
• W2073821132 hasLocation W20738211321 @default.
• W2073821132 hasLocation W20738211322 @default.
• W2073821132 hasLocation W20738211323 @default.
• W2073821132 hasLocation W20738211324 @default.
• W2073821132 hasOpenAccess W2073821132 @default.
• W2073821132 hasPrimaryLocation W20738211321 @default.
• W2073821132 hasRelatedWork W2126365059 @default.
• W2073821132 hasRelatedWork W2393078530 @default.
• W2073821132 hasRelatedWork W2487490720 @default.
• W2073821132 hasRelatedWork W2606644627 @default.
• W2073821132 hasRelatedWork W2793077515 @default.
• W2073821132 hasRelatedWork W2980097659 @default.
• W2073821132 hasRelatedWork W2981615369 @default.
• W2073821132 hasRelatedWork W3048651736 @default.
• W2073821132 hasRelatedWork W4292573045 @default.

• next